On March 20, 2015, GlaxoSmithKline (NYSEL GSK) and Theravance, Inc. (Nasdaq: THRX) announced the launch of Revlar Ellipta in Italy ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE